Vulnerability · CVE-2025-0131
An incorrect privilege management vulnerability in the OPSWAT MetaDefender Endpoint Security SDK used by the Palo Alto Networks GlobalProtect™ app on Windows devices allows a local
Published May 14, 2025 · catalog updated Feb 26, 2026 · OPSWAT MetaDefender Endpoint Security SDK
Check this week
CVE-2025-0131 is not in CISA KEV. FIRST estimates a 16.00% chance of exploitation in the next 30 days. Check whether you run OPSWAT MetaDefender Endpoint Security SDK.
Gaps on this record
- No vendor fix or required action is stored. Compare the linked advisory before you change production.
- Severity
- High7.1
- Known exploitation
- Not in CISA/VulnCheck KEV
- EPSS
- 16.00%
- Remediation
- Version ranges on file
- Affected products
- vendor OPSWAT MetaDefender Endpoint Security SDK 4.3.0 <4.3.4451
An incorrect privilege management vulnerability in the OPSWAT MetaDefender Endpoint Security SDK used by the Palo Alto Networks GlobalProtect™ app on Windows devices allows a locally authenticated non-administrative Windows user to escalate their privileges to NT AUTHORITY\SYSTEM. However, execution requires that the local user also successfully exploits a race condition, which makes this vulnerability difficult to exploit.
Are you affected?
Enter the version you run. The result uses only the ranges stored on this record.
The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.
- vendor OPSWAT MetaDefender Endpoint Security SDK 4.3.0 <4.3.44514.3.0 <4.3.4451
How to fix CVE-2025-0131
Recommended remediation
Affected version ranges suggest a fixed boundary. Verify against the vendor advisory for your release.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
CVE-2025-0131 is not in CISA KEV. FIRST estimates a 16.00% chance of exploitation in the next 30 days. Check whether you run OPSWAT MetaDefender Endpoint Security SDK.
Which versions are affected?
Compare what you have installed with OPSWAT MetaDefender Endpoint Security SDK 4.3.0 <4.3.4451 4.3.0 <4.3.4451. Compare the installed version with the linked vendor advisory before you change production.
What should an analyst verify?
No weakness class is stored. EPSS 16.00%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Technology hubs
Code
The project this record applies to. Exploit listings stay in References.
No public source repository is identified for this product.
Timeline
Detection, updates, and resolution for this record.
May 14, 2025 · EUVD
Detected
An incorrect privilege management vulnerability in the OPSWAT MetaDefender Endpoint Security SDK used by the Palo Alto Networks GlobalProtect™ app on Windows devices allows a locally authenticated non-administrative Windows user to escalate their privileges to NT AUTHORITY\SYSTEM. However, execution requires that the local user also successfully exploits a race condition, which makes this vulnerab
Feb 26, 2026 · EUVD
Updated
An incorrect privilege management vulnerability in the OPSWAT MetaDefender Endpoint Security SDK used by the Palo Alto Networks GlobalProtect™ app on Windows devices allows a locally authenticated non-administrative Windows user to escalate their privileges to NT AUTHORITY\SYSTEM. However, execution requires that the local user also successfully exploits a race condition, which makes this vulnerab
Sources
- CVE.orgVulnerability recordCVE-2025-0131
Official CVE identifier
cve.org - EUVDVulnerability recordEUVD-2025-14911
An incorrect privilege management vulnerability in the OPSWAT MetaDefender Endpoint Security SDK used by the Palo Alto Networks GlobalProtect™ app on Windows devices allows a locally authenticated non-administrative Windows user to escalate their privileges to NT AUTHORITY\SYSTEM
euvd.enisa.europa.eu
References
Freshness
Last verified in this catalog Oct 17, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.